首页> 美国卫生研究院文献>PLoS Clinical Trials >HIV-1 Transmission Patterns in Antiretroviral Therapy-Naïve, HIV-Infected North Americans Based on Phylogenetic Analysis by Population Level and Ultra-Deep DNA Sequencing
【2h】

HIV-1 Transmission Patterns in Antiretroviral Therapy-Naïve, HIV-Infected North Americans Based on Phylogenetic Analysis by Population Level and Ultra-Deep DNA Sequencing

机译:基于种群水平和超深度DNA测序的系统发育分析,未进行过抗逆转录病毒治疗的未感染艾滋病毒的北美地区的HIV-1传播方式

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Factors that contribute to the transmission of human immunodeficiency virus type 1 (HIV-1), especially drug-resistant HIV-1 variants remain a significant public health concern. In-depth phylogenetic analyses of viral sequences obtained in the screening phase from antiretroviral-naïve HIV-infected patients seeking enrollment in EPZ108859, a large open-label study in the USA, Canada and Puerto Rico (ClinicalTrials.gov ) were examined for insights into the roles of drug resistance and epidemiological factors that could impact disease dissemination. Viral transmission clusters (VTCs) were initially predicted from a phylogenetic analysis of population level HIV-1 pol sequences obtained from 690 antiretroviral-naïve subjects in 2007. Subsequently, the predicted VTCs were tested for robustness by ultra deep sequencing (UDS) using pyrosequencing technology and further phylogenetic analyses. The demographic characteristics of clustered and non-clustered subjects were then compared. From 690 subjects, 69 were assigned to 1 of 30 VTCs, each containing 2 to 5 subjects. Race composition of VTCs were significantly more likely to be white (72% vs. 60%; p = 0.04). VTCs had fewer reverse transcriptase and major PI resistance mutations (9% vs. 24%; p = 0.002) than non-clustered sequences. Both men-who-have-sex-with-men (MSM) (68% vs. 48%; p = 0.001) and Canadians (29% vs. 14%; p = 0.03) were significantly more frequent in VTCs than non-clustered sequences. Of the 515 subjects who initiated antiretroviral therapy, 33 experienced confirmed virologic failure through 144 weeks while only 3/33 were from VTCs. Fewer VTCs subjects (as compared to those with non-clustering virus) had HIV-1 with resistance-associated mutations or experienced virologic failure during the course of the study. Our analysis shows specific geographical and drug resistance trends that correlate well with transmission clusters defined by HIV sequences of similarity. Furthermore, our study demonstrates the utility of molecular and epidemiological analysis of VTCs for identifying population-specific risks associated with HIV-1 transmission and developing effective local healthcare strategies.
机译:导致人类免疫缺陷病毒1型(HIV-1)传播的因素,尤其是抗药性HIV-1变种,仍然是引起公众极大关注的问题。筛选阶段在初筛中从抗逆转录病毒初次感染HIV的患者中获得的病毒序列的系统发育分析,该患者正在美国,加拿大和波多黎各的一项大型开放标签研究(ClinicalTrials.gov)中寻求在EPZ108859中的注册,耐药性和可能影响疾病传播的流行病学因素的作用。病毒传播簇(VTC)最初是根据2007年从690名未接受逆转录病毒治疗的受试者中获得的人群水平HIV-1 pol序列的系统发育分析预测的。随后,使用焦磷酸测序技术通过超深度测序(UDS)对预测的VTC的稳健性进行了测试。以及进一步的系统发育分析。然后比较聚类和非聚类受试者的人口统计学特征。从690名受试者中,有69名被分配给30个VTC中的1个,每个VTC包含2至5个受试者。 VTC的种族组成明显更可能是白人(72%比60%; p = 0.04)。 VTC的逆转录酶和主要的PI抗性突变少于非簇序列(9%比24%; p = 0.002)。与男性发生性关系的男性(MSM)(68%比48%; p = Canadian0.001)和加拿大人(29%比14%; p men = 0.03)的发生率明显高于非男性。聚簇序列。在开始抗逆转录病毒治疗的515名受试者中,有33名在144周内确认了病毒学衰竭,而只有3/33名来自VTC。在研究过程中,较少的VTC受试者(与非簇状病毒受试者相比)具有抗药性相关突变或经历过病毒学衰竭的HIV-1。我们的分析显示了特定的地理和耐药性趋势,这些趋势与HIV相似序列定义的传播簇非常相关。此外,我们的研究表明,对VTC进行分子和流行病学分析可用于确定与HIV-1传播相关的特定人群风险,并制定有效的当地医疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号